COR vs COSM
Cencora, Inc. and Cosmos Health Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | COR | COSM |
|---|---|---|
| Revenue | $321.3B | $65.3M |
| Net income | $1.6B | $-19.1M |
| Gross margin | 3.6% | 12.1% |
| Net margin | 0.5% | −29.3% |
| Return on equity | 144.3% | −89.1% |
| Diluted EPS | $7.96 | −$0.63 |
| Dividend / share | $2.20 | · |
| Payout ratio | 28.1% | · |
| Free cash flow | $3.2B | $-8.5M |
| Equity | $1.5B | $18.4M |
| Net debt / equity | 2.19× | 0.17× |
| Current ratio | 0.90× | 1.00× |
| Revenue CAGR 5y | 11.1% | 3.3% |
| Profit CAGR 5y | · | · |
COR bills 4923.0× the revenue of COSM, and COSM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | COR | COSM |
|---|---|---|
| FY2025 | $321.3B | $65.3M |
| FY2024 | $294.0B | $54.4M |
| FY2023 | $262.2B | $53.4M |
| FY2022 | $238.6B | $50.3M |
| FY2021 | $214.0B | $56.2M |
| FY2020 | $189.9B | $55.4M |
| FY2019 | $179.6B | $39.7M |
| FY2018 | $167.9B | $37.1M |
| FY2017 | $153.1B | $30.0M |
| FY2016 | $146.8B | $6.8M |
Bottom line
| Fiscal year | COR | COSM |
|---|---|---|
| FY2025 | $1.6B | $-19.1M |
| FY2024 | $1.5B | $-16.2M |
| FY2023 | $1.7B | $-18.5M |
| FY2022 | $1.7B | $-13.8M |
| FY2021 | $1.5B | $-8.0M |
| FY2020 | $-3.4B | $820,786 |
| FY2019 | $855.4M | $-3.3M |
| FY2018 | $1.7B | $-9.1M |
| FY2017 | $364.5M | $-6.2M |
| FY2016 | $1.4B | $-601,002 |
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$321,267,547,185 | COR |
| FY2024 | +$293,904,172,598 | COR |
| FY2023 | +$262,120,034,126 | COR |
| FY2022 | +$238,536,658,348 | COR |
| FY2021 | +$213,932,603,333 | COR |
| FY2020 | +$189,838,519,663 | COR |
| FY2019 | +$179,549,444,615 | COR |
| FY2018 | +$167,902,551,118 | COR |
| FY2017 | +$153,113,812,621 | COR |
| FY2016 | +$146,842,930,564 | COR |
| FY2015 | +$135,961,269,198 | COR |
| FY2014 | +$119,561,487,978 | COR |
| FY2013 | +$87,958,264,631 | COR |
COR has reported the higher revenue in every one of these 13 fiscal years. The gap has widened since the earliest year compared.
13 of 19 comparable fiscal years — a year missing data on either side is not counted.
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +29.8 pp | COR |
| FY2024 | +30.3 pp | COR |
| FY2023 | +35.4 pp | COR |
| FY2022 | +28.2 pp | COR |
| FY2021 | +28.5 pp | COR |
| FY2020 | −3.3 pp | COSM |
| FY2019 | +8.8 pp | COR |
| FY2018 | +25.4 pp | COR |
| FY2017 | +20.9 pp | COR |
| FY2016 | +9.9 pp | COR |
| FY2015 | +1252.8 pp | COR |
| FY2014 | −78.9 pp | COSM |
| FY2013 | −26.8 pp | COSM |
The higher net margin has changed hands between COR and COSM over this period.
13 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
COSM's net margin has been more volatile than COR's over the 13 comparable fiscal years — 332.9 percentage points of standard deviation against 0.7.
13 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between COR and COSM over these 13 fiscal years — COR led in 10 and COSM in 3.
13 of 19 comparable fiscal years — a year missing data on either side is not counted.